Yakult
the daily-dose lactobacillus drink, whose China sales recovered in 2026 through new-product launches and expanded online distribution, anchored by its single-strain Lactobacillus casei Shirota daily-dose format.
- Country
- China
Commercial
Daily-dose L. casei Shirota; China sales recovery 2026 via online/new products
cn
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Living-culture beverages beyond kombucha | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.